Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Cancers|January 21, 2022
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of ExpertsIgnazio Stanganelli, Francesco Spagnolo, Giuseppe Argenziano, et al.The Journal of Investigative Dermatology|April 9, 2010
Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cellsMichela Perego, Monica Tortoreto, Gabrina Tragni, et al.European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.Cancer Research|May 3, 2006
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursorsTiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 26, 2021
Survival in Patients With Sentinel Node-Positive Melanoma With Extranodal ExtensionAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.BMC Cancer|June 6, 2022
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, et al.Cancer Immunology, Immunotherapy : CII|April 17, 2013
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell responseChiara Camisaschi, Paola Filipazzi, Marcella Tazzari, et al.The Oncologist|August 6, 2021
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated MelanomaLorenza Di Guardo, Giovanni Randon, Francesca Corti, et al.Cancer Research|January 8, 2014
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progressionViviana Vallacchi, Elisabetta Vergani, Chiara Camisaschi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Prediction of survival in patients with thin melanoma: results from a multi-institution studyAndrea Maurichi, Rosalba Miceli, Tiziana Camerini, et al.Pageof 5